Resultados de la búsqueda 71-80 of 3345 for 구글찌라시 ✈ 18242209 ✈텔@adtopking✈✈페이지랭킹✈✈✈텔@adtopking✈✈✈키워드마케팅✈✈✈

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is investigate if functions and composition of the gut microbiome are associated with the occurrence of chemotherapy-induced ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to determine the levels of prostate cancer-derived extracellular vesicles pre- and post-local therapy (radical prostatectomy ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  6. Salud del adulto Living smoke-free - Mayo Clinic

    Infórmate sobre la salud del adulto, incluyendo salud física y mental y problemas en las relaciones y el trabajo.

  7. Control del estrés - Mayo Clinic

    Stress management: Learn why you feel stress and how to fight it.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz. The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...